BioMatrix Specialty Infusion Pharmacy Appoints Ted Kramm as Chief Executive Officer and Kathee Kramm as President
Position
Chief Executive Officer
Company
BioMatrix Infusion Pharmacy
Description
BioMatrix Specialty Infusion Pharmacy announced the sale of majority interests to Frazier Healthcare Partners and the appointment of Ted Kramm as its new Chief Executive Officer, with Kathee Kramm assuming the role of President. The appointment aims to facilitate the continued growth in the infusion pharmacy arena.
Quick answer
BioMatrix Specialty Infusion Pharmacy Appoints Ted Kramm as Chief Executive Officer and Kathee Kramm as President (June 25, 2024). BioMatrix Infusion Pharmacy is based in Plantation, Florida, United States.
- Who is the new Chief Executive Officer at BioMatrix Infusion Pharmacy?
- BioMatrix Infusion Pharmacy named Ted Kramm Chief Executive Officer, announced June 25, 2024.
- What did BioMatrix Infusion Pharmacy announce on June 25, 2024?
- BioMatrix Specialty Infusion Pharmacy announced the sale of majority interests to Frazier Healthcare Partners and the appointment of Ted Kramm as its new Chief Executive Officer, with Kathee Kramm assuming the role of President. The appointment aims to facilitate the continued growth in the infusion pharmacy arena.
- What does BioMatrix Infusion Pharmacy do?
- BioMatrix Infusion Pharmacy is a leading provider in ambulatory and home infusion services.
- Where is BioMatrix Infusion Pharmacy based?
- BioMatrix Infusion Pharmacy is based in Plantation, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Actym Therapeutics (June 25, 2024), MiMedx (June 26, 2024), Immunome Inc. (June 27, 2024) and Mosaic Diagnostics (June 27, 2024) also announced leadership changes within 45 days of BioMatrix Infusion Pharmacy.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Actym Therapeutics Appoints Mary J. Janatpour as Chief Scientific Officer and Shouryadeep Srivastava as Senior Vice President of Clinical Development (June 25, 2024)
- MiMedx Appoints Kim Moller as Chief Commercial Officer (June 26, 2024)
- Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer (June 27, 2024)
- Mosaic Diagnostics Appoints Rob Rebak as Chief Executive Officer (June 27, 2024)
- Spineart Appoints Laurent Nodé-Langlois as Chief Technology Officer (June 28, 2024)
- Alistair Simpson Appointed as President and GVP for Cochlear Implants at Advanced Bionics (July 1, 2024)
Who to call at BioMatrix Infusion Pharmacy, and when
A new leader at BioMatrix Infusion Pharmacy brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BioMatrix Infusion Pharmacy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioMatrix Infusion Pharmacy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioMatrix Infusion Pharmacy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioMatrix Infusion Pharmacy changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioMatrix Infusion Pharmacy changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.